Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea
· Delayed Price · Currency is KRW 1,609.00
+10.00 (0.63%)
At close: Dec 5, 2025
Xcell Therapeutics Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 923.01 | 7,764 | 1,239 | 5,436 | 14,632 | 6,662 | Upgrade
|
| Short-Term Investments | 300 | 35.67 | 120 | 120 | - | 8 | Upgrade
|
| Trading Asset Securities | - | 1,002 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 1,223 | 8,802 | 1,359 | 5,556 | 14,632 | 6,670 | Upgrade
|
| Cash Growth | -89.75% | 547.78% | -75.55% | -62.03% | 119.39% | 701.34% | Upgrade
|
| Accounts Receivable | 240.4 | 54.71 | 282.87 | 264.4 | 159.42 | 26.28 | Upgrade
|
| Other Receivables | 290.97 | 455.24 | 333.93 | 368.52 | 109.59 | 384.62 | Upgrade
|
| Receivables | 531.37 | 509.96 | 616.8 | 632.92 | 269.01 | 410.9 | Upgrade
|
| Inventory | 1,719 | 697.92 | 804.25 | 686.9 | 500.67 | 680.19 | Upgrade
|
| Prepaid Expenses | - | 10.6 | - | - | - | - | Upgrade
|
| Other Current Assets | 471.89 | 491.19 | 60.41 | 339.89 | 22.45 | 6.22 | Upgrade
|
| Total Current Assets | 3,945 | 10,512 | 2,840 | 7,216 | 15,425 | 7,767 | Upgrade
|
| Property, Plant & Equipment | 4,537 | 4,472 | 5,355 | 7,372 | 7,515 | 5,773 | Upgrade
|
| Long-Term Investments | 992.08 | 1,099 | 34.78 | 31.69 | 19.81 | 7.93 | Upgrade
|
| Other Intangible Assets | 733.74 | 537.35 | 125.05 | 307.51 | 238.75 | 247.1 | Upgrade
|
| Long-Term Accounts Receivable | 0 | -0 | -0 | -0 | -0 | 0 | Upgrade
|
| Other Long-Term Assets | 348.34 | 269.81 | 2,113 | 582.39 | 503.45 | 273.4 | Upgrade
|
| Total Assets | 10,556 | 16,890 | 10,468 | 15,509 | 23,702 | 14,068 | Upgrade
|
| Accounts Payable | 128.69 | 125.57 | 133.66 | 90 | 227.29 | 464.82 | Upgrade
|
| Accrued Expenses | 328.76 | 295.36 | 263.38 | 277.52 | 244.79 | 234.77 | Upgrade
|
| Short-Term Debt | 4,200 | 3,500 | 4,000 | 4,000 | 4,000 | 1,400 | Upgrade
|
| Current Portion of Long-Term Debt | 58.32 | 87.56 | 72.5 | - | - | 20 | Upgrade
|
| Current Portion of Leases | 534.54 | 465.62 | 589.68 | 449.1 | 453.31 | 413.96 | Upgrade
|
| Other Current Liabilities | 518.09 | 432.39 | 383.32 | 370.56 | 332.31 | 3,483 | Upgrade
|
| Total Current Liabilities | 5,768 | 4,906 | 5,443 | 5,187 | 5,258 | 6,017 | Upgrade
|
| Long-Term Debt | 1,103 | 1,132 | 1,148 | 870 | 870 | 2,821 | Upgrade
|
| Long-Term Leases | 473.56 | 515.99 | 695.9 | 527.77 | 868.12 | 252.73 | Upgrade
|
| Pension & Post-Retirement Benefits | 977.23 | 693.4 | 288.17 | - | 93.87 | 405.13 | Upgrade
|
| Other Long-Term Liabilities | 611.6 | 520.26 | 510.64 | 440.67 | 387.31 | 3,188 | Upgrade
|
| Total Liabilities | 8,934 | 7,769 | 8,085 | 7,026 | 7,477 | 12,683 | Upgrade
|
| Common Stock | 5,469 | 5,459 | 4,582 | 4,380 | 4,376 | 1,494 | Upgrade
|
| Additional Paid-In Capital | 58,144 | 57,993 | 42,711 | 39,913 | 39,860 | 18,153 | Upgrade
|
| Retained Earnings | -63,302 | -55,717 | -46,071 | -36,835 | -28,407 | -19,358 | Upgrade
|
| Comprehensive Income & Other | 1,311 | 1,386 | 1,162 | 1,025 | 395.85 | 342.59 | Upgrade
|
| Total Common Equity | 1,622 | 9,121 | 2,384 | 8,483 | 16,225 | 632.37 | Upgrade
|
| Shareholders' Equity | 1,622 | 9,121 | 2,384 | 8,483 | 16,225 | 1,385 | Upgrade
|
| Total Liabilities & Equity | 10,556 | 16,890 | 10,468 | 15,509 | 23,702 | 14,068 | Upgrade
|
| Total Debt | 6,370 | 5,702 | 6,506 | 5,847 | 6,191 | 4,907 | Upgrade
|
| Net Cash (Debt) | -5,147 | 3,100 | -5,147 | -290.75 | 8,441 | 1,762 | Upgrade
|
| Net Cash Growth | - | - | - | - | 378.96% | - | Upgrade
|
| Net Cash Per Share | -470.29 | 309.85 | -581.98 | -33.21 | 1019.25 | 989.27 | Upgrade
|
| Filing Date Shares Outstanding | 10.95 | 10.92 | 9.16 | 8.76 | 8.75 | 2.99 | Upgrade
|
| Total Common Shares Outstanding | 10.95 | 10.92 | 9.16 | 8.76 | 8.75 | 2.99 | Upgrade
|
| Working Capital | -1,823 | 5,605 | -2,602 | 2,029 | 10,167 | 1,750 | Upgrade
|
| Book Value Per Share | 148.14 | 835.38 | 260.10 | 968.50 | 1854.01 | 211.63 | Upgrade
|
| Tangible Book Value | 888.28 | 8,584 | 2,258 | 8,176 | 15,986 | 385.27 | Upgrade
|
| Tangible Book Value Per Share | 81.13 | 786.16 | 246.46 | 933.39 | 1826.73 | 128.94 | Upgrade
|
| Land | 370.53 | 370.53 | 370.53 | 1,971 | 1,971 | 1,971 | Upgrade
|
| Buildings | 1,268 | 1,624 | 1,624 | 1,624 | 1,624 | 1,624 | Upgrade
|
| Machinery | 1,233 | 3,320 | 3,059 | 2,952 | 2,433 | 2,107 | Upgrade
|
| Construction In Progress | - | - | - | - | 278.4 | 0.92 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.